{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:16:06Z","timestamp":1791353766809,"version":"4.3.1"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Protein Cell"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s13238-010-0016-z","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T05:13:59Z","timestamp":1265346839000},"page":"124-132","source":"Crossref","is-referenced-by-count":49,"title":["Molecular and cellular bases of chronic myeloid leukemia"],"prefix":"10.1093","volume":"1","author":[{"given":"Yaoyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,2,6]]},"reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1182\/blood.V78.12.3259.3259","volume":"78","author":"H.G. Ahuja","year":"1991","unstructured":"Ahuja, H.G., Jat, P.S., Foti, A., Bar-Eli, M., and Cline, M.J. (1991). Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 78, 3259\u20133268.","journal-title":"Blood"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M. Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100, 3983\u20133988.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","volume":"306","author":"C.R. Bartram","year":"1983","unstructured":"Bartram, C.R., de Klein, A., Hagemeijer, A., van Agthoven, T., Geurts van Kessel, A., Bootsma, D., Grosveld, G., Ferguson-Smith, M.A., Davies, T., Stone, M., et al. (1983). Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 306, 277\u2013280.","journal-title":"Nature"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","volume":"233","author":"Y. Ben-Neriah","year":"1986","unstructured":"Ben-Neriah, Y., Daley, G.Q., Mes-Masson, A.M., Witte, O.N., and Baltimore, D. (1986). The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene. Science 233, 212\u2013214.","journal-title":"Science"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","volume":"101","author":"R. Bhatia","year":"2003","unstructured":"Bhatia, R., Holtz, M., Niu, N., Gray, R., Snyder, D.S., Sawyers, C.L., Arber, D.A., Slovak, M.L., and Forman, S.J. (2003). Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 101, 4701\u20134707.","journal-title":"Blood"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D. Bonnet","year":"1997","unstructured":"Bonnet, D., and Dick, J.E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3, 730\u2013737.","journal-title":"Nat Med"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/leu.2008.392","volume":"23","author":"I. Bruns","year":"2009","unstructured":"Bruns, I., Czibere, A., Fischer, J.C., Roels, F., Cadeddu, R.P., Buest, S., Bruennert, D., Huenerlituerkoglu, A.N., Stoecklein, N.H., Singh, R., et al. (2009). The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence. Leukemia 23, 892\u2013899.","journal-title":"Leukemia"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(84)90997-8","volume":"1","author":"E. Canaani","year":"1984","unstructured":"Canaani, E., Gale, R.P., Steiner-Saltz, D., Berrebi, A., Aghai, E., and Januszewicz, E. (1984). Altered transcription of an oncogene in chronic myeloid leukaemia. Lancet 1, 593\u2013595.","journal-title":"Lancet"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.emboj.7600502","volume":"24","author":"A. Catalano","year":"2005","unstructured":"Catalano, A., Rodilossi, S., Caprari, P., Coppola, V., and Procopio, A. (2005). 5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation. EMBO J 24, 170\u2013179.","journal-title":"EMBO J"},{"key":"16_CR10","doi-asserted-by":"crossref","unstructured":"Chen, Y., Hu, Y., Michaels, S., Segal, D., Brown, D., and Li, S. (2009a). Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice. Leukemia. In Press.","DOI":"10.1038\/leu.2009.52"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y. Chen","year":"2009","unstructured":"Chen, Y., Hu, Y., Zhang, H., Peng, C., and Li, S. (2009b). Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet 41, 783\u2013792.","journal-title":"Nat Genet"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"28954","DOI":"10.1074\/jbc.M101170200","volume":"276","author":"Z. Dai","year":"2001","unstructured":"Dai, Z., Kerzic, P., Schroeder, W.G., and McNiece, I.K. (2001). Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abl prevents Abl interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis. J Biol Chem 276, 28954\u201328960.","journal-title":"J Biol Chem"},{"key":"16_CR13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"B.J. Druker","year":"2001","unstructured":"Druker, B.J., Talpaz, M., Resta, D.J., Peng, B., Buchdunger, E., Ford, J.M., Lydon, N.B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001). Efficacy and safety of a specific inhibitor of the BCRABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344, 1031\u20131037.","journal-title":"N Engl J Med"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/330386a0","volume":"330","author":"E. Fainstein","year":"1987","unstructured":"Fainstein, E., Marcelle, C., Rosner, A., Canaani, E., Gale, R.P., Dreazen, O., Smith, S.D., and Croce, C.M. (1987). A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature 330, 386\u2013388.","journal-title":"Nature"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1073\/pnas.88.14.6293","volume":"88","author":"E. Feinstein","year":"1991","unstructured":"Feinstein, E., Cimino, G., Gale, R.P., Alimena, G., Berthier, R., Kishi, K., Goldman, J., Zaccaria, A., Berrebi, A., and Canaani, E. (1991). p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci U S A 88, 6293\u20136297.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1073\/pnas.58.4.1468","volume":"58","author":"P.J. Fialkow","year":"1967","unstructured":"Fialkow, P.J., Gartler, S.M., and Yoshida, A. (1967). Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci U S A 58, 1468\u20131471.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9343(77)90124-3","volume":"63","author":"P.J. Fialkow","year":"1977","unstructured":"Fialkow, P.J., Jacobson, R.J., and Papayannopoulou, T. (1977). Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte\/macrophage. Am J Med 63, 125\u2013130.","journal-title":"Am J Med"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/sj.leu.2401467","volume":"13","author":"S. Ghaffari","year":"1999","unstructured":"Ghaffari, S., Daley, G.Q., and Lodish, H.F. (1999). Growth factor independence and BCR\/ABL transformation: promise and pitfalls of murine model systems and assays. Leukemia 13, 1200\u20131206.","journal-title":"Leukemia"},{"key":"16_CR19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0092-8674(95)90277-5","volume":"82","author":"A. Goga","year":"1995","unstructured":"Goga, A., McLaughlin, J., Afar, D.E., Saffran, D.C., and Witte, O.N. (1995). Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell 82, 981\u2013988.","journal-title":"Cell"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"S.M. Graham","year":"2002","unstructured":"Graham, S.M., Jorgensen, H.G., Allan, E., Pearson, C., Alcorn, M.J., Richmond, L., and Holyoake, T.L. (2002). Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99, 319\u2013325.","journal-title":"Blood"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1084\/jem.158.1.9","volume":"158","author":"J. Groffen","year":"1983","unstructured":"Groffen, J., Heisterkamp, N., Stephenson, J.R., van Kessel, A.G., de Klein, A., Grosveld, G., and Bootsma, D. (1983). c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia. J Exp Med 158, 9\u201315.","journal-title":"J Exp Med"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","volume":"36","author":"J. Groffen","year":"1984","unstructured":"Groffen, J., Stephenson, J.R., Heisterkamp, N., de Klein, A., Bartram, C.R., and Grosveld, G. (1984). Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36, 93\u201399.","journal-title":"Cell"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1038\/sj.onc.1204023","volume":"19","author":"A.W. Gross","year":"2000","unstructured":"Gross, A.W., and Ren, R. (2000). Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells. Oncogene 19, 6286\u20136296.","journal-title":"Oncogene"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1128\/MCB.19.10.6918","volume":"19","author":"A.W. Gross","year":"1999","unstructured":"Gross, A.W., Zhang, X., and Ren, R. (1999). Bcr-Abl with an SH3 deletion retains the ability To induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy. Mol Cell Biol 19, 6918\u20136928.","journal-title":"Mol Cell Biol"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/299747a0","volume":"299","author":"N. Heisterkamp","year":"1982","unstructured":"Heisterkamp, N., Groffen, J., Stephenson, J.R., Spurr, N.K., Goodfellow, P.N., Solomon, E., Carritt, B., and Bodmer, W.F. (1982). Chromosomal localization of human cellular homologues of two viral oncogenes. Nature 299, 747\u2013749.","journal-title":"Nature"},{"key":"16_CR26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tcb.2003.11.003","volume":"14","author":"S.E. Hernandez","year":"2004","unstructured":"Hernandez, S.E., Krishnaswami, M., Miller, A.L., and Koleske, A.J. (2004). How do Abl family kinases regulate cell shape and movement? Trends Cell Biol 14, 36\u201344.","journal-title":"Trends Cell Biol"},{"key":"16_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","volume":"23","author":"Y. Hu","year":"2009","unstructured":"Hu, Y., Chen, Y., Douglas, L., and Li, S. (2009). beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia 23, 109\u2013116.","journal-title":"Leukemia"},{"key":"16_CR28","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","volume":"103","author":"Y. Hu","year":"2006","unstructured":"Hu, Y., Swerdlow, S., Duffy, T.M., Weinmann, R., Lee, F.Y., and Li, S. (2006). Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph + leukemia in mice. Proc Natl Acad Sci U S A 103, 16870\u201316875.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0145-2126(98)00097-6","volume":"22","author":"B.A. Jennings","year":"1998","unstructured":"Jennings, B.A., and Mills, K.I. (1998). c-myc locus amplification and the acquisition of trisomy 8 in the evolution of chronic myeloid leukaemia. Leuk Res 22, 899\u2013903.","journal-title":"Leuk Res"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra061808","volume":"355","author":"C.T. Jordan","year":"2006","unstructured":"Jordan, C.T., Guzman, M.L., and Noble, M. (2006). Cancer stem cells. N Engl J Med 355, 1253\u20131261.","journal-title":"N Engl J Med"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199012203232506","volume":"323","author":"H.R. Knapp","year":"1990","unstructured":"Knapp, H.R. (1990). Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med 323, 1745\u20131748.","journal-title":"N Engl J Med"},{"key":"16_CR32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature01572","volume":"423","author":"J. Lessard","year":"2003","unstructured":"Lessard, J., and Sauvageau, G. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255\u2013260.","journal-title":"Nature"},{"key":"16_CR33","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1093\/emboj\/20.23.6793","volume":"20","author":"S. Li","year":"2001","unstructured":"Li, S., Couvillon, A.D., Brasher, B.B., and Van Etten, R.A. (2001). Tyrosine phosphorylation of Grb2 by Bcr\/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling. EMBO J 20, 6793\u20136804.","journal-title":"EMBO J"},{"key":"16_CR34","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","volume":"189","author":"S. Li","year":"1999","unstructured":"Li, S., Ilaria, R.L., Jr., Million, R.P., Daley, G.Q., and Van Etten, R.A. (1999). The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 189, 1399\u20131412.","journal-title":"J Exp Med"},{"key":"16_CR35","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","volume":"273","author":"T. Maehama","year":"1998","unstructured":"Maehama, T., and Dixon, J.E. (1998). The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273, 13375\u201313378.","journal-title":"J Biol Chem"},{"key":"16_CR36","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1128\/MCB.13.12.7587","volume":"13","author":"J.R. McWhirter","year":"1993","unstructured":"McWhirter, J.R., Galasso, D.L., and Wang, J.Y. (1993). A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol Cell Biol 13, 7587\u20137595.","journal-title":"Mol Cell Biol"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","volume":"88","author":"J.V. Melo","year":"1996","unstructured":"Melo, J.V. (1996). The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88, 2375\u20132384.","journal-title":"Blood"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V96.2.664","volume":"96","author":"R.P. Million","year":"2000","unstructured":"Million, R.P., and Van Etten, R.A. (2000). The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr\/Abl tyrosine kinase. Blood 96, 664\u2013670.","journal-title":"Blood"},{"issue":"Suppl1","key":"16_CR39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/10428199309047856","volume":"11","author":"F. Mitelman","year":"1993","unstructured":"Mitelman, F. (1993). The cytogenetic scenario of chronic myeloid leukemia. Leuk Lymphoma 11Suppl 1, 11\u201315.","journal-title":"Leuk Lymphoma"},{"key":"16_CR40","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"C.G. Mullighan","year":"2007","unstructured":"Mullighan, C.G., Goorha, S., Radtke, I., Miller, C.B., Coustan-Smith, E., Dalton, J.D., Girtman, K., Mathew, S., Ma, J., Pounds, S.B., et al. (2007). Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758\u2013764.","journal-title":"Nature"},{"key":"16_CR41","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V99.12.4531","volume":"99","author":"M. Nieborowska-Skorska","year":"2002","unstructured":"Nieborowska-Skorska, M., Hoser, G., Kossev, P., Wasik, M.A., and Skorski, T. (2002). Complementary functions of the antiapoptotic protein A1 and serine\/threonine kinase pim-1 in the BCR\/ABL-mediated leukemogenesis. Blood 99, 4531\u20134539.","journal-title":"Blood"},{"key":"16_CR42","first-page":"911","volume":"29","author":"P.C. Nowell","year":"1962","unstructured":"Nowell, P.C., and Hungerford, D.A. (1962). Chromosome studies in human leukemia. IV. Myeloproliferative syndrome and other atypical myeloid disorders. J Natl Cancer Inst. 29, 911\u2013931.","journal-title":"J Natl Cancer Inst."},{"key":"16_CR43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nrc1232","volume":"3","author":"R. Pardal","year":"2003","unstructured":"Pardal, R., Clarke, M.F., and Morrison, S.J. (2003). Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3, 895\u2013902.","journal-title":"Nat Rev Cancer"},{"key":"16_CR44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/mt.2008.254","volume":"17","author":"C.Y. Park","year":"2009","unstructured":"Park, C.Y., Tseng, D., and Weissman, I.L. (2009). Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Mol Ther 17, 219\u2013230.","journal-title":"Mol Ther"},{"key":"16_CR45","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/MCB.13.3.1728","volume":"13","author":"A.M. Pendergast","year":"1993","unstructured":"Pendergast, A.M., Gishizky, M.L., Havlik, M.H., and Witte, O.N. (1993). SH1 domain autophosphorylation of P210 BCR\/ABL is required for transformation but not growth factor independence. Mol Cell Biol 13, 1728\u20131736.","journal-title":"Mol Cell Biol"},{"key":"16_CR46","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood.V84.8.2391.2391","volume":"84","author":"M. Prokocimer","year":"1994","unstructured":"Prokocimer, M., and Rotter, V. (1994). Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood 84, 2391\u20132411.","journal-title":"Blood"},{"key":"16_CR47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0092-8674(83)90389-6","volume":"34","author":"R. Prywes","year":"1983","unstructured":"Prywes, R., Foulkes, J.G., Rosenberg, N., and Baltimore, D. (1983). Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell 34, 569\u2013579.","journal-title":"Cell"},{"key":"16_CR48","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","volume":"13","author":"L. Puil","year":"1994","unstructured":"Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P.G., Arlinghaus, R., and Pawson, T. (1994). Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J 13, 764\u2013773.","journal-title":"EMBO J"},{"key":"16_CR49","doi-asserted-by":"crossref","first-page":"8347","DOI":"10.1074\/jbc.274.13.8347","volume":"274","author":"L.E. Rameh","year":"1999","unstructured":"Rameh, L.E., and Cantley, L.C. (1999). The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 274, 8347\u20138350.","journal-title":"J Biol Chem"},{"key":"16_CR50","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R. Ren","year":"2005","unstructured":"Ren, R. (2005). Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 5, 172\u2013183.","journal-title":"Nat Rev Cancer"},{"key":"16_CR51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature01593","volume":"423","author":"T. Reya","year":"2003","unstructured":"Reya, T., Duncan, A.W., Ailles, L., Domen, J., Scherer, D.C., Willert, K., Hintz, L., Nusse, R., and Weissman, I.L. (2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409\u2013414.","journal-title":"Nature"},{"key":"16_CR52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T. Reya","year":"2001","unstructured":"Reya, T., Morrison, S.J., Clarke, M.F., and Weissman, I.L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105\u2013111.","journal-title":"Nature"},{"key":"16_CR53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2008.01.036","volume":"132","author":"D.J. Rossi","year":"2008","unstructured":"Rossi, D.J., Jamieson, C.H., and Weissman, I.L. (2008). Stems cells and the pathways to aging and cancer. Cell 132, 681\u2013696.","journal-title":"Cell"},{"key":"16_CR54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"J.D. Rowley","year":"1973","unstructured":"Rowley, J.D. (1973). Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290\u2013293.","journal-title":"Nature"},{"key":"16_CR55","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood.V76.9.1819.1819","volume":"76","author":"G. Saglio","year":"1990","unstructured":"Saglio, G., Guerrasio, A., Rosso, C., Zaccaria, A., Tassinari, A., Serra, A., Rege-Cambrin, G., Mazza, U., and Gavosto, F. (1990). New type of Bcr\/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 76, 1819\u20131824.","journal-title":"Blood"},{"key":"16_CR56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1535-6108(02)00074-0","volume":"1","author":"M. Sattler","year":"2002","unstructured":"Sattler, M., Mohi, M.G., Pride, Y.B., Quinnan, L.R., Malouf, N.A., Podar, K., Gesbert, F., Iwasaki, H., Li, S., Van Etten, R.A., et al. (2002). Critical role for Gab2 in transformation by BCR\/ABL. Cancer Cell 1, 479\u2013492.","journal-title":"Cancer Cell"},{"key":"16_CR57","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0092-8674(91)90012-N","volume":"65","author":"P.L. Schwartzberg","year":"1991","unstructured":"Schwartzberg, P.L., Stall, A.M., Hardin, J.D., Bowdish, K.S., Humaran, T., Boast, S., Harbison, M.L., Robertson, E.J., and Goff, S.P. (1991). Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65, 1165\u20131175.","journal-title":"Cell"},{"key":"16_CR58","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"E. Shtivelman","year":"1985","unstructured":"Shtivelman, E., Lifshitz, B., Gale, R.P., and Canaani, E. (1985). Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315, 550\u2013554.","journal-title":"Nature"},{"key":"16_CR59","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood.V85.8.2013.bloodjournal8582013","volume":"85","author":"H. Sill","year":"1995","unstructured":"Sill, H., Goldman, J.M., and Cross, N.C. (1995). Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 85, 2013\u20132016.","journal-title":"Blood"},{"key":"16_CR60","first-page":"5821","volume":"63","author":"S.K. Singh","year":"2003","unstructured":"Singh, S.K., Clarke, I.D., Terasaki, M., Bonn, V.E., Hawkins, C., Squire, J., and Dirks, P.B. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res 63, 5821\u20135828.","journal-title":"Cancer Res"},{"key":"16_CR61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1097-2765(03)00274-0","volume":"12","author":"K.M. Smith","year":"2003","unstructured":"Smith, K.M., Yacobi, R., and Van Etten, R.A. (2003). Autoinhibition of Bcr-Abl through its SH3 domain. Mol Cell 12, 27\u201337.","journal-title":"Mol Cell"},{"key":"16_CR62","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/MCB.7.5.1955","volume":"7","author":"K. Stam","year":"1987","unstructured":"Stam, K., Heisterkamp, N., Reynolds, F.H., Jr., and Groffen, J. (1987). Evidence that the phl gene encodes a 160,000-dalton phosphor-protein with associated kinase activity. Mol Cell Biol 7, 1955\u20131960.","journal-title":"Mol Cell Biol"},{"key":"16_CR63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","volume":"95","author":"V. Stambolic","year":"1998","unstructured":"Stambolic, V., Suzuki, A., de la Pompa, J.L., Brothers, G.M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J.M., Siderovski, D.P., and Mak, T.W. (1998). Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29\u201339.","journal-title":"Cell"},{"key":"16_CR64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35077219","volume":"411","author":"J. Taipale","year":"2001","unstructured":"Taipale, J., and Beachy, P.A. (2001). The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349\u2013354.","journal-title":"Nature"},{"key":"16_CR65","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1182\/blood.V92.12.4758","volume":"92","author":"N. Takahashi","year":"1998","unstructured":"Takahashi, N., Miura, I., Saitoh, K., and Miura, A.B. (1998). Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood 92, 4758\u20134763.","journal-title":"Blood"},{"key":"16_CR66","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0092-8674(91)90011-M","volume":"65","author":"V.L. Tybulewicz","year":"1991","unstructured":"Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153\u20131163.","journal-title":"Cell"},{"key":"16_CR67","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1242\/jcs.02606","volume":"118","author":"P. Varnai","year":"2005","unstructured":"Varnai, P., Bondeva, T., Tamas, P., Toth, B., Buday, L., Hunyady, L., and Balla, T. (2005). Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners. J Cell Sci 118, 4879\u20134888.","journal-title":"J Cell Sci"},{"key":"16_CR68","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0092-8674(95)90350-X","volume":"80","author":"J.W. Voncken","year":"1995","unstructured":"Voncken, J.W., van Schaick, H., Kaartinen, V., Deemer, K., Coates, T., Landing, B., Pattengale, P., Dorseuil, O., Bokoch, G.M., Groffen, J., et al. (1995). Increased neutrophil respiratory burst in bcr-null mutants. Cell 80, 719\u2013728.","journal-title":"Cell"},{"key":"16_CR69","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.tcb.2005.07.004","volume":"15","author":"J.C. Wang","year":"2005","unstructured":"Wang, J.C., and Dick, J.E. (2005). Cancer stem cells: lessons from leukemia. Trends Cell Biol 15, 494\u2013501.","journal-title":"Trends Cell Biol"},{"key":"16_CR70","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2003-01-0062","volume":"102","author":"J.A. Wertheim","year":"2003","unstructured":"Wertheim, J.A., Perera, S.A., Hammer, D.A., Ren, R., Boettiger, D., and Pear, W.S. (2003). Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML development. Blood 102, 2220\u20132228.","journal-title":"Blood"},{"key":"16_CR71","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V80.12.2983.2983","volume":"80","author":"C.A. Westbrook","year":"1992","unstructured":"Westbrook, C.A., Hooberman, A.L., Spino, C., Dodge, R.K., Larson, R.A., Davey, F., Wurster-Hill, D.H., Sobol, R.E., Schiffer, C., and Bloomfield, C.D. (1992). Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood 80, 2983\u20132990.","journal-title":"Blood"},{"key":"16_CR72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","volume":"22","author":"S. Wong","year":"2004","unstructured":"Wong, S., and Witte, O.N. (2004). The BCR-ABL story: bench to bedside and back. Annu Rev Immunol 22, 247\u2013306.","journal-title":"Annu Rev Immunol"},{"key":"16_CR73","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1242\/jcs.00622","volume":"116","author":"P.J. Woodring","year":"2003","unstructured":"Woodring, P.J., Hunter, T., and Wang, J.Y. (2003). Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases. J Cell Sci 116, 2613\u20132626.","journal-title":"J Cell Sci"},{"key":"16_CR74","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrm2335","volume":"9","author":"M.P. Wymann","year":"2008","unstructured":"Wymann, M.P., and Schneiter, R. (2008). Lipid signalling in disease. Nat Rev Mol Cell Biol 9, 162\u2013176.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"16_CR75","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature04747","volume":"441","author":"J. Zhang","year":"2006","unstructured":"Zhang, J., Grindley, J.C., Yin, T., Jayasinghe, S., He, X.C., Ross, J.T., Haug, J.S., Rupp, D., Porter-Westpfahl, K.S., Wiedemann, L.M., et al. (2006). PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441, 518\u2013522.","journal-title":"Nature"},{"key":"16_CR76","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V92.10.3829","volume":"92","author":"X. Zhang","year":"1998","unstructured":"Zhang, X., and Ren, R. (1998). Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 92, 3829\u20133840.","journal-title":"Blood"},{"key":"16_CR77","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/MCB.21.3.840-853.2001","volume":"21","author":"X. Zhang","year":"2001","unstructured":"Zhang, X., Subrahmanyam, R., Wong, R., Gross, A.W., and Ren, R. (2001). The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl. Mol Cell Biol 21, 840\u2013853.","journal-title":"Mol Cell Biol"},{"key":"16_CR78","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","volume":"12","author":"C. Zhao","year":"2007","unstructured":"Zhao, C., Blum, J., Chen, A., Kwon, H.Y., Jung, S.H., Cook, J.M., Lagoo, A., and Reya, T. (2007). Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12, 528\u2013541.","journal-title":"Cancer Cell"},{"key":"16_CR79","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C. Zhao","year":"2009","unstructured":"Zhao, C., Chen, A., Jamieson, C.H., Fereshteh, M., Abrahamsson, A., Blum, J., Kwon, H.Y., Kim, J., Chute, J.P., Rizzieri, D., et al. (2009). Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458, 776\u2013779.","journal-title":"Nature"}],"container-title":["Protein &amp; Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13238-010-0016-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13238-010-0016-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13238-010-0016-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:38:18Z","timestamp":1676374698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/proteincell\/article\/1\/2\/124\/6842775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1007\/s13238-010-0016-z","relation":{},"ISSN":["1674-800X","1674-8018"],"issn-type":[{"value":"1674-800X","type":"print"},{"value":"1674-8018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}